The Schistosomiasis Control Initiative

Donate to The Schistosomiasis Control Initiative (SCI)

100% of your donation (minus credit card fees, if applicable) goes to the cause of your choice. Rethink Charity Forward will strive to extend its “zero fees” initiative indefinitely.

If you are making a donation of $1000 or more, or a monthly donation of $200 or more, please send an email to siobhan@rtcharity.org so we can provide you with alternative donation options that could cut back significantly on third-party fees.

The Schistosomiasis Control Initiative (SCI) works with Ministries of Health and Education in sub-Saharan Africa and Yemen to treat their populations for the parasitic “worm” infections, schistosomiasis and soil-transmitted helminthiasis (STH). These infections affect the poorest and most marginalised communities in the world. 

All dollar and gift amounts on this donation page are in Canadian Dollars (CAD).

$
Money raised for the Schistosomiasis Control Initiative through RC Forward

The SCI at Imperial College London works with Ministries of Health and Education in sub-Saharan Africa and Yemen to treat their populations for the parasitic “worm” infections, schistosomiasis and soil-transmitted helminthiasis (STH). These infections affect the poorest and most marginalised communities in the world. 

The World Health Organization estimates that 206 million people have schistosomiasis and 1.5 billion have STH.

These infections can result in: anaemia, stunted growth, reduced school attendance, impaired cognitive development, reduced worker productivity, and internal organ damage. 

However, studies show that treating schistosomiasis and STH can: 

  • Increase school attendance by up to 255 
  • Increase future earnings by 40% 
  • Reverse damaging effects of infections 

The majority of SCI-supported programmes treat school-age children (5-14 years old), but can include at-risk adults. 

Treatment is cost-effective. £1 provides treatment for three people. 

Since its foundation in 2002, SCI has supported the delivery of over 159 million treatments for these infections.